Following the NAD+ claim past the drip
I want to know what ‘cellular energy’ would mean for an ordinary day.
The useful fact inside the grand language
NAD+ helps cells use energy. That's the useful idea behind the long name, nicotinamide adenine dinucleotide. I don't need the name to sound impressive; I need the claim about the drip to hold up.
‘More energy’ sounds like getting through an afternoon without running out of steam. A change in blood chemistry is a different result. I look for a study that connects the treatment being offered to the improvement being promised.
What the infusion research measured
In a small 2019 NAD+ infusion study, NAD+ didn't detectably rise in plasma, the liquid part of blood, for the first two hours. The researchers tracked blood and urine chemistry. This wasn't proof that a drip reverses ageing or helps people live longer.
A separate study of oral nicotinamide riboside raised blood NAD+. Nicotinamide riboside is a precursor: something the body can use to make NAD+. That result belongs to an oral precursor, not an NAD+ drip.
I wouldn't use either finding as a promise about how you'll feel. The substance, the way it's given and the outcome all have to match. ‘NAD+ went up’ leaves the question about your afternoon unanswered.
Preparation is part of the safety question
FDA's November 2024 notice describes severe chills, shaking, vomiting and fatigue after NAD+ injections, sometimes requiring medical treatment. The agency says these reactions fit excessive endotoxins, harmful bacterial components. It warns against food-grade ingredients in sterile medicines without proper processing.
That doesn't mean every drip is contaminated. It does mean the preparation needs its own explanation. Compounding means making a medicine to order. Compounded drugs are not FDA-approved, and FDA doesn't check their safety, effectiveness or quality before they're sold.
I wouldn't read a bad reaction as a sign that ‘detox’ is working. The reported symptoms belong in a safety conversation. An appealing story about the ingredient can't do the work of that conversation.
The question I would bring back to the menu
What change is this treatment meant to bring, and what human study tested that change? I'd want an answer in the same everyday words as the concern. A pleasant setting and a scientific name aren't that answer.
A licensed U.S. clinician can assess persistent fatigue or other symptoms and discuss treatment. Picking a drip doesn't replace that assessment. The sources behind this entry cover blood chemistry, an oral precursor and preparation risks. Each answers a smaller question than ‘Will I feel better?’
Reading dated October 27, 2026. Sources and their limits.